A new World Health Organization (WHO) road map for neglected tropical diseases (NTDs) proposes ambitious targets and inn...
Novavax, Inc., a biotechnology company developing next-generation vaccines for serious infectious diseases, announced th...
GSK, PATH, and Bharat Biotech (BBIL) on Jan 27, 2021, announced the signing of a product transfer agreement for the mala...
Merck, a leading science and technology company, and the END Fund have announced their partnership to provide Rwanda wit...
Norway based CEPI, the Coalition for Epidemic Preparedness Innovations, has opened a new funding opportunity to support ...
Eppendorf and the journal Science are now accepting applications for the 2021 Eppendorf & Science Prize for Neurobio...
COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardle...
Thermo Fisher Scientific Inc., the world leader in serving science, on Jan 19, 2021 announced it has entered into a...
Pfizer Inc and BioNTech SE on Jan 20, 2021 announced results from an in vitro study that provides additional d...
Novartis and GSK has announced the launch of a collaboration to support high-quality scientific research investigating t...
More than 2,800 scientists from 130 countries gathered in a virtual forum last week hosted by the World Health Organizat...
The sixth meeting of the Emergency Committee (EC) convened by the WHO Director-General under the International Heal...
Thermo Fisher Scientific Inc. and Groupe Novasep SAS, a leading supplier of services and technologies for the life scien...
PerkinElmer, Inc. announced on Jan 14, 2021 that its PerkinElmer® New Coronavirus Nucleic Acid D...
KSQ Therapeutics, a biotechnology company using its proprietary CRISPRomics® discovery platform to systematically sc...
The past few weeks have seen the regulatory approval of multiple safe and effective vaccines against Sars-CoV-2, the v...
The four leading international health and humanitarian organizations on Jan 12, 2021, announced the establishment of a g...
PerkinElmer, Inc. and Oxford Immunotec Global PLC have reached an agreement on terms under which PerkinElmer w...
